Braveheart! [R for BE/BA]

posted by Helmut Homepage – Vienna, Austria, 2020-07-11 15:38 (309 d 07:01 ago) – Posting: # 21674
Views: 11,925

Hi ElMaestro,

» it is rather experimental.


» […] which means we have:
» A variance for T (combined within and between)
» A variance for within-R
» A variance for between-R

Correct. Will be interesting what you get because \(\sigma_{wT}^2+\sigma_{bT}^2\):
0.04367 (Phoenix) and 0.03771 (SAS).

» Hessian, positive definite, etc.. [image]all this comes down to the details of SAS's or WinNonlin's optimiser. I am playing around with optim in R (BFGS, L-BFGS-B bounded, and Nelder-Mead) and with one of my own making.

If you succeed, the community will love you. Might win you the Fields medal.

As long as a genius (you?) is not able to come up with a solution working in all cases, I can only repeat:

Avoid partial replicate designs!

It might not be possible to evaluate the study for ABE (though RSABE works in any case).

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,462 posts in 4,487 threads, 1,514 registered users;
online 4 (0 registered, 4 guests [including 2 identified bots]).
Forum time: Sunday 22:40 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz